Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection. | Int J Mol Sci | 2022 | 35682757 | PubTator, text mining | PubMed |
| Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding-Who Is Binding Who and Why? | Int J Mol Sci | 2022 | 35682724 | PubTator, text mining | PubMed |
| CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies. | Cells | 2022 | 35681499 | PubTator, text mining | PubMed |
| Immune Cells in Hyperprogressive Disease under Immune Checkpoint-Based Immunotherapy. | Cells | 2022 | 35681453 | PubTator, text mining | PubMed |
| Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021. | J Transl Med | 2022 | 35672823 | PubTator, text mining | PubMed |
| Editorial: Immunoglobulin Glycosylation Analysis: State-of-the-Art Methods and Applications in Immunology. | Front Immunol | 2022 | 35669775 | PubTator, text mining | PubMed |
| Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics. | PLoS One | 2022 | 35657812 | PubTator, text mining | PubMed |
| Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level. | Front Cell Dev Biol | 2022 | 35646915 | PubTator, text mining | PubMed |
| An Integrated Systematic Analysis and the Clinical Significance of Hepcidin in Common Malignancies of the Male Genitourinary System. | Front Genet | 2022 | 35646093 | PubTator, text mining | PubMed |
| A genome-wide functional genomics approach uncovers genetic determinants of immune phenotypes in type 1 diabetes. | Elife | 2022 | 35638288 | PubTator, text mining | PubMed |
| Characteristics of alveolar macrophages in bronchioalveolar lavage fluids from active tuberculosis patients identified by single-cell RNA sequencing. | J Biomed Res | 2022 | 35635159 | PubTator, text mining | PubMed |
| Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma. | Trends Cancer | 2022 | 35624002 | PubTator, text mining | PubMed |
| Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. | iScience | 2022 | 35620424 | PubTator, text mining | PubMed |
| A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases. | Mediators Inflamm | 2022 | 35620115 | PubTator, text mining | PubMed |
| The Role of C-Type Lectin Receptor Signaling in the Intestinal Microbiota-Inflammation-Cancer Axis. | Front Immunol | 2022 | 35619716 | PubTator, text mining | PubMed |
| Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis. | Front Immunol | 2022 | 35619690 | PubTator, text mining | PubMed |
| Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma. | Sci Rep | 2022 | 35610242 | PubTator, text mining | PubMed |
| Dihydroarteannuin Ameliorates Collagen-Induced Arthritis Via Inhibiting B Cell Activation by Activating the FcγRIIb/Lyn/SHP-1 Pathway. | Front Pharmacol | 2022 | 35592412 | PubTator, text mining | PubMed |
| Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes. | Front Immunol | 2022 | 35592337 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity. | Nat Commun | 2022 | 35589689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=46